Introduction
The Basic and Clinical Intestinal Disorders section (BCID) represents a community of clinical, translational and basic scientists interested in disease-focused and pathwaydriven processes underlying:
Celiac disease and food intolerances; Radiation, chemotherapy, and hypoxia-induced injury and repair; Diarrhea, malabsorption and enteropathies.
Microbial pathogenesis and mechanisms of microbehost cross talk; Nutrient, solute, salt and water transport; Epithelial cell and molecular biology;
Epithelial barrier function and wound repair;
Epithelial functions in innate immunity and inflammation; and Irritable bowel syndrome.
Our section aims to foster collaboration among interactive scientific communities by featuring outstanding basic, translational and clinical research in these areas. 
Research Fora

Introduction
The AGA Council section "Cellular & Molecular Gastroenterology" (CMG) has broad interests in the basic mechanisms underlying digestive diseases and gastrointestinal biology. The section's membership has interests representing many areas of cutting-edge science, including growth factors, stem cells, cellular differentiation, epigenetics, mechanisms of receptor function, basic physiology and cell biology, luminal chemosensing, intestinal inflammation, and mucosal injury and healing. CMG strives to invite outside speakers who are leading scientists in their fields to present forward-looking scientific programming at DDW.
We have an exciting lineup for DDW 2018. CMG will sponsor a distinguished abstract plenary session, 4 research symposia, 7 research fora, and 11 poster sessions. We look forward to seeing you at DDW!
Research Fora
Topical Research Fora have been organized based on the top-scored abstracts. Four of the seven are cross-sectional, drawing abstracts from several sections.
Saturday, June 2, 2018: "Stem Cells in the Origin and Progression of Cancer", "Cellular Plasticity in Regeneration and Metaplasia" 
Research Mentor Award
Established in 2010, the Research Mentor Award recognizes an individual for his or her achievements as an outstanding mentor in a specific area of research.
The award will be presented to Charalabos Pothoulakis, MD during Cellular & Molecular Gastroenterology Distinguished Abstract Plenary and Section Business Meeting, Monday June 4, 4:00 p.m., 102a.
Introduction
The mission of the Clinical Practice section is to promote the optimum delivery of high quality, cost-effective gastrointestinal healthcare. Best practices will primarily be identified through cutting-edge research in areas such as epidemiology, population health screening, outcomes research, performance metrics, health economics, systematic reviews, practice management and medical education.
Research Fora
The CP section will feature seven research fora, which will have oral abstract presentations and invited speakers centered on general themes. These include the following:
Saturday 
Poster Sessions
CP is sponsoring 13 poster sessions. The topics include the following: "Epidemiology and Outcomes of Functional GI Disease," "Epidemiology and Outcomes of GI Bleeding," "Epidemiology of GI Disease," "GI Cancer Epidemiology and Screening," "Health Care Delivery," "Health Disparities," "Health Economics," "IBD Epidemiology and Clinical Outcomes," "Medical Education," "Patient Reported Outcomes," "Population Colorectal Cancer Screening," "Process Improvement," and "Systematic Reviews.
Research Mentor Award
The award will be presented to Amnon Sonnenberg, MD, MSc during Missed Lesions and Appropriate Follow-Up of Screening and Surveillance, Saturday, June 2, 10-11:30 a.m., room 207.
Introduction
The EGD section continues to heavily contribute to the educational and research mission of the AGA Institute and remains a highly visible section at Digestive Disease Week® (DDW). The attendance at DDW continues to be robust, with nearly all of the EGD section's clinical sessions exceeding expected capacity. The section is diverse in regards to representation of multiple upper GI diseases including esophagus, stomach, and duodenum. Advances continue to develop in the area of esophageal reflux and motility testing (e.g., high resolution manometry and mucosal impedance measurements), endoscopic reflux therapies as well as continued strong interest in both clinical and basic research in eosinophilic esophagitis and Barrett's esophagus. Dominant areas of investigation in this section include esophageal physiologic testing, eosinophilic esophagitis, H. pylori infection and its chronic implications, GERD and extraesophageal GERD, Barrett's esophagus, esophageal and gastric dysmotility, and GI bleeding.
Research Fora
The EGD section will feature nine research fora, which will have oral abstract presentations and invited speakers centered on general themes. These include the following:
Saturday, June 2, 2018: "Advances in the Diagnosis and Management of Barrett's Esophagus", "H. pylori Epidemiology, Diagnosis and Treatment" Sunday, June 3, 2018:, "Advances in Extraesophageal Manifestations of GERD", "Advances in the Diagnosis of GERD", "Advances in the Management of Eosinophilic Esophagitis", "Advances in the Therapy of GERD", "New Concepts in the Pathogenesis of Barrett's Esophagus", "Scientific Advances in Eosinophilic Esophagitis"
Tuesday, June 5, 2018: "H. 
Poster Sessions
EGD is sponsoring 15 poster sessions. The topics include the following: "Barrett's Esophagus: Diagnosis, Management and Surveillance," "Eosinophilic Esophagitis: Clinical," "Eosinophilic Esophagitis: Translational or Basic," "Esophageal Motility and Dysmotility," "Functional Dyspepsia, Nausea and Vomiting," "Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Therapy," "GERD/Barrett's: Pathogenesis," "GERD: Complications and Extra-Esophageal Presentations," "GERD: Diagnostic Testing," "GERD: Medical, Surgical and Endoscopic Therapies," "Helicobacter pylori: Epidemiology, Diagnosis and Outcomes," "Helicobacter pylori: Host Response and Pathogenesis," "Helicobacter pylori: Treatment and Antimicrobial Resistance," "Mucosal Defense, Secretion, Injury, Repair and Healing," and "Peptic Ulcer Disease and Non-Variceal UGI Bleeding."
Research Mentor Award
The award will be presented to Nicholas J. Shaheen, MD, MPH, AGAF during the Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary: The Best of Barrett's, EOE, GERD, H. pylori, Tuesday, June 5, 10-11:30 a.m., 10-10:06 a.m., room 201.
Introduction
The Gastrointestinal Oncology Section is dedicated to expanding and advancing the science and practice of gastroenterology primarily by providing educational leadership in topics central to the initiation, progression, diagnosis and treatment of gastrointestinal tract cancers by programming high quality and the latest advances in clinical, translational, and basic science research. The foci of our section are divided under two broad, inter-related themes of organ systems and gastrointestinal cancer biology.
Research Fora
The Gastrointestinal Oncology Research Fora were developed to include many of the most outstanding abstracts submitted to our section for presentation in Washington, DC. Fora topics reflect the most current research interests of our section members, and bring together thematically related abstracts to foster greater interactions between presenters and the audience. The Gastrointestinal Oncology Distinguished Abstract Plenary is delighted to present six outstanding abstracts. Topics will be of interest to clinicians as well as basic scientists and will explore novel biomarkers, habits associated with colon cancer survival, and mechanisms of carcinogenesis. 
Symposia
The invited speaker symposia this year are an exciting collection of cutting-edge basic research methodologies and forward-looking clinical reviews designed to provoke discussion and debate. We encourage GI Oncology members to attend the GRG Symposium entitled "GRG Spring Symposium: Towards a New Generation of Ecologically Friendly Antibiotics" 2009 Nobel Laureate in Chemistry, Ada Yonath, will discuss her work exploring the mechanisms by which many common antibiotics target microbes.
Introduction
The Growth, Development & Child Health (GDCH) section serves dual roles in both attracting basic scientists focused on the biological pathways that regulate the growth, development and differentiation of the gastrointestinal tract as well as clinicians interested in gastrointestinal diseases affecting the pediatric population.
Research Fora
The GDCH section will feature 7 fora, the majority of which will showcase both abstract and invited presentations. 
Introduction
The Imaging, Endoscopy & Advanced Technology (IEAT) section of the AGA Council identifies research submitted to Digestive Disease Week® (DDW) that incorporates novel applications or improvements to existing technology or new techniques that image or treat disorders of the gastrointestinal tract, liver, bile ducts, gallbladder or pancreas. Along with other sections of the council, it designs multidisciplinary symposia and sessions for DDW that are designed to appeal to clinicians and scientists in gastroenterology, surgery and radiology.
Research Fora
The IEAT section will feature four research fora. 
Introduction
The IMIBD section executes the AGA's strategic plan by providing an international forum to present and evaluate the most exciting and innovative research in the field. By providing a forum for debate, collaboration and an exchange of ideas, the IMIBD section helps define what is state-of-the-art care in IBD and pushes the boundaries of science in search of a cure. Established and emerging leaders collate this information to provide education and training to both the next generation of researchers as well as for providers caring for patients with IBD. This enhanced knowledge leads to improved practice and quality, ultimately showing the value of section through the work of its diverse members.
The Liver & Biliary (LB) section is dedicated to advancing the science and clinical practice of gastroenterology by providing leadership in topics central to the epidemiology, diagnosis and treatment of acute and chronic hepatobiliary diseases. The section is focused on providing state-of-the-art programming in all aspects of clinical, translational and basic science research as it relates to liver disease and transplantation. It is the second largest section in the AGA Council, and collaborates with multiple AGA sections and the American Association for the Study of Liver Diseases (AASLD) in offering abstract-driven sessions at Digestive Disease Week® (DDW).
Research Fora
The LB section will feature 5 fora, the majority of which will showcase both abstract and invited presentations. 
The MMDGT is offering 4 research sessions that feature outstanding speakers who will present findings that highlight emerging areas of discovery that advance our understanding of the role of the gut microbiome in health and disease. MMDGT is also happy to co-sponsor many sessions this year as the microbiome is a cross cutting field of interest that goes beyond this section. Please be sure to use the mobile planner and app once its available to see all the MMDGT related sessions. 
Symposia
The MMDGT symposia will feature outstanding speakers, selected abstract-driven talks, and topics in formats that provides attendees with what's current and hot, but also a look into the future of the microbiome field. A mix of basic science, translational, and clinical topics will be presented. 1. To attract the best science and cutting-edge research in neurogastroenterology and GI motility for presentation at Digestive Disease Week® (DDW).
2. To educate and train gastroenterologists, research scientists, surgeons, physiologists, trainees, nurses and technicians on the latest developments in the field.
3. To foster interdisciplinary basic science, translational and clinical research.
4. To lead and critically examine the development of novel tools for studying neurogastroenterology and motility disorders, and gut and brain interactions, both at the bench side and for patient care.
Research Fora
The NGM section will feature 11 research fora in which cutting-edge science will be discussed. These include joint sessions co-sponsored by other sections.
Saturday, June 2, 2018: "Enteric Neurobiology: Cell and Molecular Biology", "Esophageal Motility and Dysmotility", "Functional Dyspepsia, Nausea and Vomiting", "Gastroparesis and Small Intestine Dysmotility" 
Distinguished Abstract Plenary
The NGM section will hold its distinguished abstract plenary on Monday, June 4. Do not miss the best and most outstanding research in the field that will be presented at this plenary. Attendees will be able to listen and deliberate the most significant advance from bench to translational to clinical neurogastroenterology and motility. In addition, they will see the presentation of the 2018 Research Mentor Award to Richard W. Mccallum, MD, AGAF, at the end of this session. 
Research Mentor Award
Introduction
In recent years, DDW programming by the Obesity, Metabolism and Nutrition (OMN) section has emphasized subject areas that have appealed to a majority of meeting attendees, especially those affiliated not only with the OMN section, but also other sections with which we share common interests, as reflected by our strong participation in cross-sectional programming. Our programming includes fora and symposia highlighting related topics, including bariatric surgery, GI neuroendocrinology and metabolism, new and innovative endoscopic and other treatments of obesity and diabetes, fatty liver disease, GI regulation of energy balance, weight and metabolic function, microbiota and metabolic regulation, and nutrition and metabolism across the life cycle. Nutritional support in all of its forms used in the management of a variety of diseases, including obesity, intestinal failure and inflammatory bowel disease, as well as nutrient absorption and metabolism, have also continued to be the focus of OMN programming. The OMN section has also endeavored to strike a balance between basic research to shed light on disease mechanisms, including pre-clinical studies to develop new therapies, and clinical and translational research to better describe disease phenotypes and test new therapeutic approaches.
The Pancreatic Disorders (PAN) Section is dedicated to presenting the most up-to-date clinical and basic science information to as many dedicated members as possible. It provides an all-inclusive group of experts as speakers, who are whetted out by large number of stakeholders and peer reviewed on the best platform in the world.
